首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >FORMULATION AND IN-VITRO EVALUATION OF FAST DISSOLVING FILM CONTAINING AMLODIPINE BESYLATE SOLID DISPERSION
【24h】

FORMULATION AND IN-VITRO EVALUATION OF FAST DISSOLVING FILM CONTAINING AMLODIPINE BESYLATE SOLID DISPERSION

机译:含巯基苯磺酸苯磺酸盐固体分散体的快速溶解膜的制备及体外评价

获取原文
           

摘要

Objective: This study concerned with preparation and in-vitro evaluation of fast dissolving film of amlodipine besylate solid dispersion, since amlodipine besylate is a sparingly soluble orally administered drug and the rate of absorption is often controlled by the rate of dissolution. Materials and method: The rate of dissolution can be increased by incorporating the drug in a fast dissolving dosage form as a solid dispersion that prepared using polyethylene glycol (PEG6000) or polyvinyl pyrrolidone (PVP) in different ratios and different methods of preparation. The fast dissolving films were prepared using sodium carboxy methyl cellulose (SCMC) in different concentration orhydroxypropyl methyl cellulose (HPMC) also different concentration of glycerin were used. Different factors affecting the dissolution rate of the solid dispersion and fast dissolving film were studied. Results: It was seen that as the ratio of drug to PEG6000 or PVP in solid dispersion increased the release rate increased and the solvent evaporation method gave greater release than fusion method. In fast dissolving film it was seen that as the concentration of SCMC increased the release rate decreased significantly and as the concentration of glycerin increased the release rate increased significantly. Discussion: The release rate increased with increasing the ratio of drug to PEG6000 or PVP in solid dispersionsince both of them are water soluble carriers; so increase their amount in solid dispersion leading to increase the wettability and dispersibility of drug from the dispersion resulting in dissolution of drug in hydrophilic carrier
机译:目的:本研究涉及苯磺酸氨氯地平固体分散体的快速溶解膜的制备和体外评价,因为苯磺酸氨氯地平是一种微溶的口服药物,吸收率通常由溶出度控制。材料和方法:可以通过将药物以固体分散体形式掺入快速溶解剂型中,从而提高溶出速率,该固体分散体是使用聚乙二醇(PEG6000)或聚乙烯吡咯烷酮(PVP)以不同的比例和不同的制备方法制备的。使用不同浓度的羧甲基纤维素钠(SCMC)或羟丙基甲基纤维素(HPMC)制备速溶膜,也使用不同浓度的甘油。研究了影响固体分散体和速溶膜溶解速率的不同因素。结果:可以看出,随着药物与PEG6000或PVP在固体分散体中的比例增加,释放速率增加,溶剂蒸发法比融合法释放更多。在快速溶解膜中,可以看到随着SCMC浓度的增加,释放速率显着降低,而随着甘油浓度的增加,释放速率显着增加。讨论:释放速率随着药物与PEG6000或PVP在固体分散体中的比例的增加而增加,因为它们都是水溶性载体。因此增加其在固体分散体中的量,从而导致药物从分散体的润湿性和分散性增加,从而导致药物在亲水性载体中溶解

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号